Home
Conditions
Immunologic Deficiency Syndromes

Clinical trial condition

Immunologic Deficiency Syndromes

Explore clinical trials studying Immunologic Deficiency Syndromes. Study availability and eligibility vary by location and protocol.

6,132 public trials 395 recruiting studies

Refine in advanced search Browse all conditions

Immunologic Deficiency Syndromes trial results

Completed

A European Post-Authorisation Observational Study Of Patients With Hereditary Angioedema

NCT01541423

Conditions: Angioedema, Angioedemas, Hereditary, Cardiovascular Diseases, +14 more
Locations: Universitair Ziekenhuis Antwerpen (UZA) Antwerp, Edegem, Belgium

Clinic St-Luc University Hospital Brussels, Belgium

CHU d'Angers Angers, France

Hôpital Claude-Huriez Lille, France

View all 20 locations

View Trial Details

Completed

Stanford Universities: The Stanford HIV Aging Cohort

NCT01401348

Conditions: Acquired Immunodeficiency Syndrome, Blood-Borne Infections, Communicable Diseases, +13 more
Locations: Stanford University School of Medicine Stanford, California, United States

View Trial Details

Completed

Time to Protection and Adherence Requirements of Raltegravir With or Without Lamivudine in Protection From HIV Infection

NCT03205566

Conditions: Acquired Immunodeficiency Syndrome, Blood-Borne Infections, Communicable Diseases, +14 more
Locations: Harrison Wing, Guy's Hospital London, United Kingdom

View Trial Details

Completed

Ibalizumab Plus Optimized Background Regimen in Treatment-Experienced Patients With Multi-Drug Resistant HIV-1

NCT02707861

Conditions: Acquired Immunodeficiency Syndrome, Blood-Borne Infections, Communicable Diseases, +14 more
Locations: Long Beach Education and Research Consultants Long Beach, California, United States

Southern California Permanente Medical Group Los Angeles, California, United States

Ruane Clinical Research Institute Inc. Los Angeles, California, United States

Charles R. Drew University of Medicine and Science, Clinical and Translational Research Center Los Angeles, California, United States

View all 32 locations

View Trial Details

Completed

Triggered Escalating Real-time Adherence (TERA) Intervention

NCT03292432

Conditions: Behavior, Blood-Borne Infections, Communicable Diseases, +17 more
Locations: University of Colorado Denver Children's Hospital Colorado Aurora, Colorado, United States

Broward Health Childrens Diagnostic and Treatment Center (CDTC) Fort Lauderdale, Florida, United States

University of Florida Center for HIV/AIDS, Research, Education & Service Jacksonville, Florida, United States

Emory University School of Medicine Atlanta, Georgia, United States

View Trial Details

Completed

Real-world CANadian CUvitru Non-Interventional Study in Subjects Transitioning From Subcutaneous Immunoglobulin (CANCUN)

NCT03716700

Conditions: Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Genetic Diseases, Inborn, Immune System Diseases, +3 more
Locations: University of McMaster Hamilton, Ontario, Canada

Grand River Allergy Kitchener, Ontario, Canada

Toronto Allergists Toronto, Ontario, Canada

View Trial Details

Completed

The Effects of Genetic Differences Among AIDS Patients on Cytomegalovirus Retinitis

NCT00341172

Conditions: AIDS, Acquired Immunodeficiency Syndrome, Blood-Borne Infections, +17 more
Locations: Johns Hopkins University Baltimore, Maryland, United States

View Trial Details

Completed

Expanding HIV Testing Among Uganda Adults Who Utilize Traditional Healers

NCT03718871

Conditions: Acquired Immunodeficiency Syndrome, Behavior, Blood-Borne Infections, +17 more
Locations: Mbarara University of Science and Technology Mbarara, Uganda

View Trial Details

Completed

A Relative Bioavailability and Food-Effect Study of GSK3640254 Tablet and Capsule Formulations in Healthy Participants

NCT04263142

Conditions: Acquired Immunodeficiency Syndrome, Blood-Borne Infections, Communicable Diseases, +13 more
Locations: GSK Investigational Site Austin, Texas, United States

View Trial Details

Completed

TCR Alpha/Beta Depletion for HSCT From Haploidentical and Unrelated Donors in the Treatment of PID

NCT02327351

Conditions: Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Genetic Diseases, Inborn, Hematopoietic Stem Cell Transplantation, +4 more
Locations: Dmitry Rogachev Federal Research and Clinical Centre of Paediatric Haematology, Oncology and Immunology Moscow, Russia

View Trial Details

Immunologic Deficiency Syndromes

Immunologic Deficiency Syndromes trial results

Related conditions